Eliem Therapeutics, Inc. - Enterprise Value

The Enterprise Value as of June 2026 (TTM) for Eliem Therapeutics, Inc. (ELYM) is 772.83M

According to Eliem Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 772.83M. This represents a change of 256.74% compared to the average of 216.64M of the last 4 quarters.

Eliem Therapeutics, Inc. (ELYM) Historical Enterprise Value (quarterly & annually)

How has ELYM Enterprise Value performed in the past?

The mean historical Enterprise Value of Eliem Therapeutics, Inc. over the last ten years is 101.08M. The current 772.83M Enterprise Value has changed 76.36% with respect to the historical average. Over the past ten years (40 quarters), ELYM's Enterprise Value was at its highest in in the March 2026 quarter at 459.34M. The Enterprise Value was at its lowest in in the March 2020 quarter at 0.

Eliem Therapeutics, Inc. (ELYM) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Eliem Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Eliem Therapeutics, Inc. (ELYM) Average Enterprise Value

How has ELYM Enterprise Value performed in the past?

The current Enterprise Value of Eliem Therapeutics, Inc. (ELYM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Eliem Therapeutics, Inc. (ELYM) Enterprise Value vs. Peers

How is ELYM’s Enterprise Value compared to its peers?

Eliem Therapeutics, Inc.’s Enterprise Value is greater than Checkpoint Therapeutics, Inc. (334.68M), greater than scPharmaceuticals Inc. (313.84M), greater than Revance Therapeutics, Inc. (722.13M), greater than Vigil Neuroscience, Inc. (346.93M), greater than Orchard Therapeutics plc (369.77M), greater than G1 Therapeutics, Inc. (402.64M), greater than Inozyme Pharma, Inc. (279.36M), greater than iTeos Therapeutics, Inc. (245.99M), greater than Y-mAbs Therapeutics, Inc. (332.06M), greater than Alaunos Therapeutics, Inc. (4.90M),

Build a custom stock screener for Eliem Therapeutics, Inc. (ELYM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eliem Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Eliem Therapeutics, Inc. (ELYM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Eliem Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.